Indocin Articles
Rocket shown to have anti-ulcer properties
13 May 2009
FTC sues Ovation over PDA monopoly
22 December 2008
Iroko buys Canadian antibiotic rights
22 October 2007
AlphaRx selects ARX82 for advanced preclin development
24 September 2007
Indaflex misses Ph II endpoints
21 May 2007
Iroko Pharma gets two Merck & Co drugs
2 April 2007
AlphaRx initiates Phase I for Indaflex
28 February 2005
OTC analgesics sales in Pacific Rim markets
3 August 2000
Merck & Co's Vioxx to get FDA review in April
4 March 1999
Studies Reveal Side Effect Burden With Fosamax
15 October 1998
Colon Cancer Scare With Drugs
3 September 1998
Zeneca Allays Fears Of Near-Term Product Gap
4 December 1997
Yamanouchi To Develop Searle's Celecoxib In Japan
29 April 1996
German Self-Medication Book Published
18 September 1995
-Yamanouchi has begun marketing Serastar
31 July 1995
Japanese News In Brief
23 January 1995
COX-2 Inhibitor Shows Promise
15 August 1994
Re-Engineering Japanese R&D - Again
25 July 1994
NET PROFITS LEAP AT SUMITOMO PHARMA
7 March 1994
MSD CUTS UK PRICES
4 October 1993
INDOMETHACIN IN ALZHEIMERS
23 August 1993
IBUPROFEN OFF DRUGS LIST IN JAPAN
2 August 1993
US OTC ANALGESICS - A 1992 RETROSPECTIVE
4 January 1993
CORTECS' NSAID TARGETING STRATEGY
6 April 1992
CORTECS' NSAID TARGETING STRATEGY
6 April 1992
FDA CRITERIA FOR PHARMACIES
17 February 1992
NEW CHEMICAL ENTITIES UPDATE FOR 1991
10 February 1992
ANALGESICS IN THE USA -- AN OPEN DOOR FOR P&G?
6 January 1992
Showing 1-33 of 33 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
